Hypercalcaemia in malignancy.
作者信息
Ralston S H, Gallacher S J, Parel U, Boyle I T
出版信息
BMJ. 1989 Jul 15;299(6692):181-2. doi: 10.1136/bmj.299.6692.181-c.
Abstract
摘要
相似文献
1
Hypercalcaemia in malignancy.恶性肿瘤中的高钙血症
BMJ. 1989 Jul 15;299(6692):181-2. doi: 10.1136/bmj.299.6692.181-c.
2
Pathogenesis and management of cancer associated hypercalcaemia.癌症相关性高钙血症的发病机制与管理
Cancer Surv. 1994;21:179-96.
3
Malignant hypercalcemia. The choice of therapy.恶性高钙血症。治疗方法的选择。
Arch Intern Med. 1991 Mar;151(3):437-8. doi: 10.1001/archinte.151.3.437.
4
The treatment of hypercalcaemia of malignancy.恶性肿瘤高钙血症的治疗
Clin Endocrinol (Oxf). 1991 Feb;34(2):155-7. doi: 10.1111/j.1365-2265.1991.tb00286.x.
5
Hypercalcaemia in malignancy.恶性肿瘤中的高钙血症
BMJ. 1989 Jun 3;298(6686):1468-9. doi: 10.1136/bmj.298.6686.1468.
6
Hypercalcaemia due to malignancy. Role of the kidney and treatment.恶性肿瘤所致高钙血症。肾脏的作用及治疗
Contrib Nephrol. 1982;33:178-96.
7
The management of hypercalcaemia in advanced cancer.晚期癌症高钙血症的管理
Int J Palliat Nurs. 2013 Jul;19(7):327-31. doi: 10.12968/ijpn.2013.19.7.327.
8
Bisphosphonate treatment of bone metastases and hypercalcemia of malignancy.双膦酸盐治疗骨转移和恶性肿瘤高钙血症。
Oncology (Williston Park). 1991 Aug;5(8):55-60; discussion 60-2, 65.
9
[Treatment of hypercalcemia of tumoral origin with two diphosphonates].
Schweiz Med Wochenschr. 1980 Nov 29;110(48):1822-4.
10
[The significance of early diagnosis of cancer-related hypercalcaemia].[癌症相关高钙血症早期诊断的意义]
Orv Hetil. 2013 Sep 1;154(35):1367-73. doi: 10.1556/OH.2013.29665.
本文引用的文献
1
Hypercalcaemia of malignancy: evidence for a nonparathyroid humoral agent with an effect on renal tubular handling of calcium.恶性肿瘤所致高钙血症：关于一种影响肾小管钙处理的非甲状旁腺体液因子的证据。
Clin Sci (Lond). 1984 Feb;66(2):187-91. doi: 10.1042/cs0660187.
2
Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy.体液和转移因子在恶性肿瘤高钙血症发病机制中的相对作用。
Br Med J (Clin Res Ed). 1984 May 12;288(6428):1405-8. doi: 10.1136/bmj.288.6428.1405.
3
Comparison of intravenous (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate and volume repletion in tumour-induced hypercalcaemia.
Lancet. 1983 Jul 30;2(8344):239-43. doi: 10.1016/s0140-6736(83)90231-3.
4
Clinical experience with aminohydroxypropylidene bisphosphonate (APD) in the management of cancer-associated hypercalcaemia.
Q J Med. 1988 Oct;68(258):825-34.
5
Etidronate disodium in the management of malignancy-related hypercalcemia.依替膦酸二钠用于治疗恶性肿瘤相关的高钙血症。
Am J Med. 1987 Feb 23;82(2A):51-4. doi: 10.1016/0002-9343(87)90487-6.
6
Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin.联合应用氨基羟丙基二膦酸盐和降钙素治疗癌症相关性高钙血症
Br Med J (Clin Res Ed). 1986 Jun 14;292(6535):1549-50. doi: 10.1136/bmj.292.6535.1549.
7
Renal handling of calcium and sodium in metastatic and non-metastatic malignancy.转移性和非转移性恶性肿瘤中钙和钠的肾脏处理
Br Med J (Clin Res Ed). 1986 Mar 1;292(6520):583-6. doi: 10.1136/bmj.292.6520.583.
8
Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronate.
Bone. 1988;9(3):123-30. doi: 10.1016/8756-3282(88)90001-4.
9
Hypercalcaemia in malignancy.恶性肿瘤中的高钙血症
BMJ. 1989 Jun 3;298(6686):1468-9. doi: 10.1136/bmj.298.6686.1468.
Zotero 插件